Novavax
Type of vaccine: Protein subunit vaccine. It contains coded messages from moth cells that boosts immune response.
Effectiveness: 89 percent effective after both doses.
Approval: Phase III trials concluded, but not yet approved for mass distribution.
Delivery: UK ordered 60 million doses of the Novavax vaccine.
Location: If it’s approved, the vaccine will be manufactured in the UK.
Johnson & Johnson
Type of vaccine: Viral vector vaccine. Adapts a common cold virus to make it appear similar to the Covid virus.
Effectiveness: 85 percent effective against serious disease after a single dose.
Approval: Phase III trials concluded, but not yet approved for mass distribution.
Delivery: UK ordered 30 million doses of the Johnson & Johnson vaccine.
Location: If it’s approved, the vaccine will be manufactured in the US.
Published at Sun, 31 Jan 2021 12:00:00 +0000
Covid vaccines compared: All five Covid vaccines laid bare – differences and efficacy